EWTX ▲ +2.4% - Edgewise Therapeutics, Inc.
$EWTX reported Q3 2026 Adj EPS of -$0.19, missing the $1.90 estimate by 110.0%. Revenue of $0 missed the $119.2M estimate by 100.0%.
04-NOV-2026 04:45 PM ET
Share this post
More filings for $EWTX
EWTX ▼ -0.5% - Edgewise Therapeutics, Inc.Nov 4, 2026EWTX ▲ +0.1% - Edgewise Therapeutics, Inc.Nov 2, 2026EWTX ▲ +1.1% - Edgewise Therapeutics, Inc.Oct 8, 2026EWTX - Edgewise Therapeutics, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 6, 2026
View full $EWTX filing history →💬 Comments
Loading comments…
Leave a comment